Semaglutide API Synthesis Peptide for Diabetics CAS NO.910463-68-2

Semaglutide API Synthesis Peptide for Diabetics CAS NO.910463-68-2

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 30.0000 -50.0000

1 Kilogram

FOB Price:USD 30.0000 -50.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Semaglutide Semaglutide Peptide 910463-68-2

Quick Details

Appearance:white powder
Application:Supplements
PackAge:1kg/bag; 25kg/drum
ProductionCapacity:500|Kilogram|Month
Storage:Store in cool and dry places.Keep away from srong light and heat.
Transportation:fedex dhl EMS , EUB

Superiority:

Mike(Wuhan) Biotechnology Co.,Ltd. is professional in production and export of cosmetics raw materials, plant extracts, health care raw materials and chemicals.We have GMP equipped factory and lab. We are strong in research, modern quality management system and high quality sales team.Our products are widely used in cosmetics products, health care products, nutritional supplements, beverages and pharmacy.

1. All inquiries will be replied within 12 hours.

2. Dedication to quality, supply & service.

3. Strictly on selecting raw materials.

3. OEM/ODM Available.

4. Reasonable & competitive price, fast lead time.

5. Sample is available for your evaluation & Formulation development.

6. Faster delivery:Sample order in stock and 3-7 days for bulk production.

7. We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.

8. After-Sale Service:

1) International Authorized Third-Party Test For The Products You Demand.

2) 30 Days Warranty of quality of goods.

Details:

Product name:Sermaglutide

CAS No.:910463-68-2

Molecular formula:C187H291N45O59

Molecular weight:4113.64

Purity:98%

Semeglutide is a long-acting glucagon-like peptide 1 (GLP-1) analog, a GLP-1 receptor agonist, and has potential therapeutic efficacy in type II diabetes mellitus (T2DM).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.